Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NOVO-PROPAMIDE 250MG DIN 00021350

Status: Cancelled Post Market
Holder: NOVOPHARM LIMITED
Molecule: CHLORPROPAMIDE

Health Canada record

Active ingredient(s)CHLORPROPAMIDE 250 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCA10BB02 CHLORPROPAMIDE
Original market date31-Dec-1969
Current status date10-Sep-2010
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CHLORPROPAMIDE

DINProductCompanyFormStrengthStatus
00399302APO CHLORPROPAMIDE TAB 100MGAPOTEX INCTabletCHLORPROPAMIDE 100 MGCancelled Post Market
00312711APO CHLORPROPAMIDE TAB 250MGAPOTEX INCTabletCHLORPROPAMIDE 250 MGCancelled Post Market
00586773CHLORPROPAMIDE 100 TAB USPPRO DOC LIMITEETabletCHLORPROPAMIDE 100 MGCancelled Post Market
00156728CHLORPROPAMIDE TAB 250MGPRO DOC LIMITEETabletCHLORPROPAMIDE 250 MGCancelled Post Market
00430986CHLORPROPAMIDE TAB 250MGDUCHESNAY INCTabletCHLORPROPAMIDE 250 MGCancelled Post Market
00024708DIABINESE TAB 100MGPFIZER CANADA ULCTabletCHLORPROPAMIDE 100 MGCancelled Post Market
00024716DIABINESE TAB 250MGPFIZER CANADA ULCTabletCHLORPROPAMIDE 250 MGCancelled Post Market

International API supply for CHLORPROPAMIDE

0 valid EDQM Certificates of Suitability from 0 holders. 1 active FDA Drug Master Files.

Request a quote for NOVO-PROPAMIDE 250MG

How to read a Canadian DIN record